These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 9843946)

  • 1. Fractionation factors and activation energies for exchange of the low barrier hydrogen bonding proton in peptidyl trifluoromethyl ketone complexes of chymotrypsin.
    Lin J; Westler WM; Cleland WW; Markley JL; Frey PA
    Proc Natl Acad Sci U S A; 1998 Dec; 95(25):14664-8. PubMed ID: 9843946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlations of the basicity of His 57 with transition state analogue binding, substrate reactivity, and the strength of the low-barrier hydrogen bond in chymotrypsin.
    Lin J; Cassidy CS; Frey PA
    Biochemistry; 1998 Aug; 37(34):11940-8. PubMed ID: 9718318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new concept for the mechanism of action of chymotrypsin: the role of the low-barrier hydrogen bond.
    Cassidy CS; Lin J; Frey PA
    Biochemistry; 1997 Apr; 36(15):4576-84. PubMed ID: 9109667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for a strong hydrogen bond in the catalytic dyad of transition-state analogue inhibitor complexes of chymotrypsin from proton-triton NMR isotope shifts.
    Westler WM; Frey PA; Lin J; Wemmer DE; Morimoto H; Williams PG; Markley JL
    J Am Chem Soc; 2002 Apr; 124(16):4196-7. PubMed ID: 11960433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of low-barrier hydrogen bonding and oxyanion binding in transition state analogue complexes of chymotrypsin.
    Neidhart D; Wei Y; Cassidy C; Lin J; Cleland WW; Frey PA
    Biochemistry; 2001 Feb; 40(8):2439-47. PubMed ID: 11327865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A low-barrier hydrogen bond in subtilisin: 1H and 15N NMR studies with peptidyl trifluoromethyl ketones.
    Halkides CJ; Wu YQ; Murray CJ
    Biochemistry; 1996 Dec; 35(49):15941-8. PubMed ID: 8961961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The deuterium isotope effect on the NMR signal of the low-barrier hydrogen bond in a transition-state analog complex of chymotrypsin.
    Cassidy CS; Lin J; Frey PA
    Biochem Biophys Res Commun; 2000 Jul; 273(2):789-92. PubMed ID: 10873682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure of chymotrypsin-trifluoromethyl ketone inhibitor complexes: comparison of slowly and rapidly equilibrating inhibitors.
    Brady K; Wei AZ; Ringe D; Abeles RH
    Biochemistry; 1990 Aug; 29(33):7600-7. PubMed ID: 2271520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NMR studies of the role of hydrogen bonding in the mechanism of triosephosphate isomerase.
    Harris TK; Abeygunawardana C; Mildvan AS
    Biochemistry; 1997 Dec; 36(48):14661-75. PubMed ID: 9398185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantum chemical calculations on structural models of the catalytic site of chymotrypsin: comparison of calculated results with experimental data from NMR spectroscopy.
    Westler WM; Weinhold F; Markley JL
    J Am Chem Soc; 2002 Dec; 124(48):14373-81. PubMed ID: 12452711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of serine proteases by peptidyl fluoromethyl ketones.
    Imperiali B; Abeles RH
    Biochemistry; 1986 Jul; 25(13):3760-7. PubMed ID: 3527255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of chymotrypsin by peptidyl trifluoromethyl ketones: determinants of slow-binding kinetics.
    Brady K; Abeles RH
    Biochemistry; 1990 Aug; 29(33):7608-17. PubMed ID: 2271521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protonation-state dependence of hydrogen bond strengths and exchange rates in a serine protease catalytic triad: bovine chymotrypsinogen A.
    Markley JL; Westler WM
    Biochemistry; 1996 Aug; 35(34):11092-7. PubMed ID: 8780512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NMR evidence for a short, strong hydrogen bond at the active site of a cholinesterase.
    Viragh C; Harris TK; Reddy PM; Massiah MA; Mildvan AS; Kovach IM
    Biochemistry; 2000 Dec; 39(51):16200-5. PubMed ID: 11123949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The low barrier hydrogen bond (LBHB) proposal revisited: the case of the Asp... His pair in serine proteases.
    Schutz CN; Warshel A
    Proteins; 2004 May; 55(3):711-23. PubMed ID: 15103633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Properties of the His57-Asp102 dyad of rat trypsin D189S in the zymogen, activated enzyme, and alpha1-proteinase inhibitor complexed forms.
    Kaslik G; Westler WM; Gráf L; Markley JL
    Arch Biochem Biophys; 1999 Feb; 362(2):254-64. PubMed ID: 9989934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proton inventory studies of alpha-thrombin-catalyzed reactions of substrates with selected P and P' sites.
    Enyedy EJ; Kovach IM
    J Am Chem Soc; 2004 May; 126(19):6017-24. PubMed ID: 15137766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-barrier hydrogen bonding in molecular complexes analogous to histidine and aspartate in the catalytic triad of serine proteases.
    Tobin JB; Whitt SA; Cassidy CS; Frey PA
    Biochemistry; 1995 May; 34(21):6919-24. PubMed ID: 7766600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A proton-shuttle mechanism mediated by the porphyrin in benzene hydroxylation by cytochrome p450 enzymes.
    de Visser SP; Shaik S
    J Am Chem Soc; 2003 Jun; 125(24):7413-24. PubMed ID: 12797816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. pH dependence of the inhibition of chymotrypsin by a peptidyl trifluoromethyl ketone.
    Brady K; Liang TC; Abeles RH
    Biochemistry; 1989 Nov; 28(23):9066-70. PubMed ID: 2605240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.